SCHEMBL7987856

SCHEMBL7987856

COc1ccc(S(=O)(=O)N(O)[C@@H](C(N)=O)C(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 9/20 0.49
MMP2 P08253 8/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
MMP13 P45452 8/20 0.47
MMP8 P22894 7/20 0.47
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 2/20 0.46
KEAP1 Q14145 4/20 0.45
NFE2L2 Q16236 3/20 0.45
MMP1 P03956 2/20 0.45
MMP3 P08254 1/20 0.45
MMP7 P09237 1/20 0.45
F2 P00734 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386007 0.86 ADAMTS4 (0.51) MMP9MMP2CA1CA2CA9
SCHEMBL7987098 0.78 NPC1 (0.46) MMP2MMP13PKMF2PRSS1
SCHEMBL6510024 0.75 ADAMTS4 (0.68) MMP9MMP2CA1CA2CA9
SCHEMBL4916977 0.74 ALDH1A1 (0.41) CA1CA2CA9ALDH1A1KEAP1
SCHEMBL6502002 0.72 MMP13 (0.67) MMP9MMP2CA1CA2CA9
SCHEMBL7451136 0.71 MMP2 (0.57) MMP9MMP2CA1CA2CA9
SCHEMBL6465700 0.71 KEAP1 (0.50) MMP9MMP2CA1CA2CA9
SCHEMBL3868587 0.70 LMNA (0.55) MMP9MMP2MMP13MMP8MMP1
SCHEMBL6498314 0.70 ADAMTS4 (0.47) MMP9MMP2CA1CA2CA9
SCHEMBL14350865 0.70 PKM (0.52) MMP9MMP2CA1CA2MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242467-B1 (N-HYDROXYAMIDO)-ALKYLSULFONAMIDE DERIVATIVES; INHIBITORS OF TUMOR NECROSIS FACTOR AND CD23 ANTIGEN; AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, ANTIALLERGENS SMITHKLINE BEECHAM P.L.C. (GB) 2001-06-05 US claimed
US-6242467-B1 (N-HYDROXYAMIDO)-ALKYLSULFONAMIDE DERIVATIVES; INHIBITORS OF TUMOR NECROSIS FACTOR AND CD23 ANTIGEN; AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, ANTIALLERGENS SMITHKLINE BEECHAM P.L.C. (GB) 2001-06-05 US disclosed
EP-0973732-A2 ARYL- OR HETEROARYLSULFONAMIDE SUBSTITUTED HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SMITHKLINE BEECHAM PLC (GB) 2000-01-26 EP disclosed
WO-1998042659-A2 ARYL- OR HETEROARYLSULFONAMIDE SUBSTITUTED HYDROXAMIC ACID DERIVATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SMITHKLINE BEECHAM PLC (GB) 1998-10-01 WO disclosed